Copyright © 2001 by the European Society of Cardiology.
Long-term clinical outcome after coronary balloon angioplasty. Identification of a population at low risk of recurrent events during 17 years of follow-up
The Department of Cardiac Catheterization and Interventional Cardiology, Thoraxcenter, Erasmus University and University Hospital Dijkzigt Rotterdam, The Netherlands
revised August 20, 2000; accepted August 23, 2000
Abstract
Aims This study reports the clinical outcome, up to 17 years, of the first 856 consecutive patients treated by coronary angioplasty at a single centre and attempts to identify a subgroup of patients at low risk of adverse events.
Methods and Results Follow-up status was established via hospital and general practitioner records and the civil registry. Median follow-up was 16 years. The overall 5-, 10-, 15- and 17-year survival was 90%, 78%, 64% and 58%, respectively and corresponding event-free survival was 53%, 33%, 22% and 19%. After 32% of patients had experienced a major adverse cardiac event in the first year, the annual coronary re-intervention incidence thereafter and, even beyond year 10, remained at 2%3%. Using multivariable Cox regression, significant independent predictors of mortality were advanced age, diabetes, multivessel disease and impaired left ventricular function at the time of PTCA. A subgroup of 26% of the patients with none of these risk factors had a survival rate similar to the general Dutch population matched for age and gender (at 5 years: 96%, at 10 years: 89% and at 15 years: 83%).
Conclusion Although the majority of patients (>80%) experienced a further cardiac event during the 17 years after their first angioplasty procedure, in those non-diabetics under 60 years with single-vessel disease and good left ventricular function, prognosis was similar to the general population.
Key Words: PTCA, follow-up, survival, risk stratification
f1 Correspondence: Ron T. van Domburg, University Hospital Rotterdam Dijkzigt, Thoraxcenter, Location 5 Midden, Room H 539, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
References
- Gruentzig A. Transluminal dilatation of coronary artery stenosis (letter). Lancet. 1978;1:263[CrossRef][ISI][Medline]
- Gruentzig AR, Senning A, Sieganthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med. 1979;301:6167[Abstract]
- Talley JD, Hurst JW, King SB 3rd. Clinical outcome 5 years after attempted percutaneous transluminal coronary angioplasty in 427 patients. Circulation. 1988;77:820829
[Abstract/Free Full Text] - King SB 3rd, Schlumpf M. Ten-year completed follow-up of percutaneous transluminal coronary angioplasty: the early Zurich experience. J Am Coll Cardiol. 1993;22:353360[Abstract]
- Dorros G, Iyer S, Mathiak LM, Anderson AJ. The impact of balloon angioplasty of coronary artery and/or vein bypass graft lesion(s) upon the survival of patients > or =5 years after their last bypass surgery. Eur Heart J. 1993;14:13541364
[Abstract/Free Full Text] - Kelsey SF, James M, Holubkov AL, Holubkov R, Cowley MJ, Detre KM. Results of percutaneous transluminal coronary angioplasty in women, 19851986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. Circulation. 1993;87:720727
[Abstract/Free Full Text] - Wilson WS, Stone GW. Late results of percutaneous transluminal coronary angioplasty of two or more major native coronary arteries. Am J Cardiol. 1994;73:10411046[CrossRef][ISI][Medline]
- Keelan ET, Nunez BD, Grill DE, Berger PB, Holmes DR Jr, Bell MR. Comparison of immediate and long-term outcome of coronary angioplasty performed for unstable angina and rest pain in men and women. Mayo Clinic Proceedings. 1997;72:512[ISI][Medline]
- Bentivoglio LG, Detre K, Yeh W, Williams DO, Kelsey SF, Faxon DP. Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris, A report of the 19851986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. J Am Coll Cardiol. 1994;24:11951206[Abstract]
- Weintraub WS, King SB III, Douglas JS, Kosinski AS. Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease. J Am Coll Cardiol. 1995;26:142151[Abstract]
- Ruygrok PN, de Jaegere PP, van Domburg RT, van den Brand MJ, Serruys PW, de Feyter PJ. Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplast in 856 patients. J Am Coll Cardiol. 1996;27:16771699
- Hasdai D, Bell MR, Grill DE. Outcome >10 years after successful percutaneous transluminal coronary angioplasty. Am J Cardiol. 1997;79:10051011[CrossRef][ISI][Medline]
- Halon DA, Flugelman MY, Merdler A, Rennert H, Shahla J, Lewis BS. Long-term (10-year) outcome in patients with unstable angina pectoris treated by coronary balloon angioplasty. J Am Coll Cardiol. 1998;32:16031609
[Abstract/Free Full Text] - Kimura T, Yokoi H, Nakagawa Y. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334:561566
[Abstract/Free Full Text] - de Jaegere PPT, de Feijter PJ, van Domburg R. Immediate and long-term results of percutenous coronary angioplasty in patients aged 70 and over. Br Heart J. 1992;67:138143
[Abstract/Free Full Text] - N Engl J Med. 1996;335:217225
[Abstract/Free Full Text] - Henderson RA, Pocock SJ, Sharp SJ. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet. 1998;352:14191425[CrossRef][ISI][Medline]
- Veldkamp RF, Meeter K, Valk SDA, van Domburg RT, van Herwerden LA, Bogers AJJC. Mortality and repeat interventions until 20 years after aorto-coronary bypass: a follow-up study of 1041 patients. Eur Heart J. 2000;21:747753
[Abstract/Free Full Text] - J Am Coll Cardiol. 2000;35:11221129
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
K.-H. Mak and D. P. Faxon Clinical studies on coronary revascularization in patients with type 2 diabetes Eur. Heart J., June 2, 2003; 24(12): 1087 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Hamon, S Fradin, A Denizet, E Filippi-Codaccioni, G Grollier, and R Morello Prospective evaluation of the effect of an angiotensin I converting enzyme gene polymorphism on the long term risk of major adverse cardiac events after percutaneous coronary intervention Heart, March 1, 2003; 89(3): 321 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.T van Domburg, D.P Foley, A Breeman, L.A van Herwerden, and P.W Serruys Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome Eur. Heart J., April 1, 2002; 23(7): 543 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seabra-Gomes Every piece is important to build a puzzle. What can we learn from early experiences with balloon PTCA? Eur. Heart J., June 1, 2001; 22(11): 891 - 893. [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

